HAL (France)
open access
Ingénierie ciblée de la niche tumorale par vecteurs lentiviraux pour améliorer l'efficacité des cellules CAR T dans le cancer du pancréas
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal solid malignancies, with limited therapeutic options and poor clinical outcomes. Although immunotherapies have transformed the treatment of several cancers, their efficacy in PDAC remains limited. Among these approaches, adoptive
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer#383563
- Multi-omics and functional analysis of a bioengineered vascularized pancreatic cancer model reveal an immunosuppressive and therapy-resistant niche#1175207
- Direct Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic Cancer#1337807
- Macrophages Effect on Chemoresistance#1375269
- Characterization of 3D heterocellular spheroids of pancreatic ductal adenocarcinoma for the study of cell interactions in the tumor immune microenvironment#1175213
Record · ID 1425725
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive